World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms

Griffith News
14 July 2021
https://news.griffith.edu.au/2021/07/14/world-first-laboratory-study-finds-low-dose-naltrexone-may-improve-me-cfs-symptoms/

Sandy discussed her Chronic Epstein Barr Virus, CFS/ME and LDN Journey (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

Lori shares her story of LDN for ME/CFS (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Derek Enlander Talks about Low Dose Naltrexone LDN, CFS/ME 2021 (LDN) from LDN Research Trust on Vimeo.

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

Front. Immunol
31 October 2019
https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/full

Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Fatigue: Biomedicine, Health & Behavior
19 November 2019
https://www.tandfonline.com/doi/abs/10.1080/21641846.2019.1692770?journalCode=rftg20

Low-dose Naltrexone as a Treatment for Chronic Fatigue Syndrome

BMJ Case Reports
06 January 2020
https://casereports.bmj.com/content/13/1/e232502

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f

Kent Holtorf, MD - CFS/ME and Fibromyalgia (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's CFS/ME Presentation

Sarah Zielsdorf, MD, MS - Beyond Tired: CFS/ME or Not? (2017 Conference) (LDN, low dose naltrexone)

Dr Zielsdorf shares case studies of patients with CFS and ME and goes into the evidence showing that the hallmark of CFS/ME is a mitochondrial dysfunction and intense diet, nutritional antioxidant and other lifestyle modifications are the primary therapy for this disorder.